Forces of American scientists have developed an effective vaccine against breast cancer. The product has passed the first stage of clinical trials showing good results and almost no side effects.
Research Associates School of Medicine in St. Louis, Washington University are working on a vaccine for the treatment of metastatic breast cancer . The first phase of clinical trials of the drug, which involved 14 patients with this diagnosis. During the year women received the new vaccine, half of them cancer progression was observed. In the control group of 12 people who did not pass the vaccination, the tumor does not develop in only two patients.
With mammary cancer increasing the number of mammoglobina-A. The vaccine acts on the immune system so that the protein expression is observed in tumors recognize and destroy.
- Learn to work on mammoglobin - a great achievement as it is formed in 80% of cases of breast cancer, but almost never occurs in other tissues - the words lead author Dr. William Dzhillanders edition of Clinical Cancer Research. - Even despite the fact that the immune system in patients with women was severely weakened, we observed biological effect, which provided the vaccine to the immune cells in blood samples. This is encouraging.
Scientists have proved the efficacy and safety of the vaccine. Tests of the drug will be continued. To do this will attract more patients, including women in the early stage of the disease (in this case the vaccine can show results even better, because the immune system in the initial stage of the disease is much stronger). Experts also point out that a small number of patients breast cancer mammoglobin is not formed, so they have the vaccine action will be. (READ MORE)
Industry News
Go back to the main page
Немає коментарів:
Дописати коментар